We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+14.32%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.48B
AUM Growth
-$724M
Cap. Flow
-$938M
Cap. Flow %
-37.88%
Top 10 Hldgs %
48.15%
Holding
67
New
27
Increased
10
Reduced
11
Closed
18

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$95.9M
2
AGN
Allergan plc
AGN
+$89.6M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$62.5M
4
CNC icon
Centene
CNC
+$61.7M
5
UNH icon
UnitedHealth
UNH
+$55.9M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$165M
2
CVS icon
CVS Health
CVS
+$144M
3
LIVN icon
LivaNova
LIVN
+$139M
4
ISRG icon
Intuitive Surgical
ISRG
+$135M
5
CELG
Celgene Corp
CELG
+$125M

Sector Composition

Rank Sector Weight
1 Healthcare 87.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRX icon
51
Amneal Pharmaceuticals
AMRX
$5.89B
– –
-2,118,377
Closed -$28.7M
BIIB icon
52
Biogen
BIIB
$30.5B
– –
-66,780
Closed -$20.1M
BMY icon
53
Bristol-Myers Squibb
BMY
$130B
– –
-294,490
Closed -$15.3M
CI icon
54
Cigna
CI
$71.5B
– –
-584,390
Closed -$111M
CVS icon
55
CVS Health
CVS
$126B
– –
-2,328,560
Closed -$144M
DVAX
56
DELISTED
Dynavax Technologies
DVAX
– –
-4,613,280
Closed -$42.2M
EHC icon
57
Encompass Health
EHC
$11B
– –
-1,390,141
Closed -$68.2M
LIVN icon
58
LivaNova
LIVN
$4.29B
– –
-1,517,780
Closed -$139M
REGN icon
59
Regeneron Pharmaceuticals
REGN
$79.1B
– –
-440,968
Closed -$165M
SPY icon
60
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$819B
– –
-1,400,000
Closed -$350M
SPY icon
61
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$819B
– –
-285,000
Closed -$71.2M
SYK icon
62
Stryker
SYK
$129B
– –
-593,623
Closed -$107M
CLVS
63
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-600,000
Closed -$10.8M
ZSAN
64
DELISTED
Zosano Pharma Corporation
ZSAN
– –
-16,309
Closed -$1.21M
WCG
65
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-462,370
Closed -$109M
CELG
66
CALL
DELISTED
Celgene Corp
CELG
– –
-750,000
Closed -$48.1M
CELG
67
DELISTED
Celgene Corp
CELG
– –
-1,947,640
Closed -$125M
1 2
3

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q1 2019 Portfolio in Review

As of Q1 2019, HealthCor Management held 67 positions worth $2.48B, down 23% from $3.2B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

HealthCor Management withdrew a net $938M in Q1 2019, closing 18 positions and reducing 11 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $165M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 75% a quarter earlier.

Against the trend, HealthCor Management opened a new position in Allergan plc worth $90.4M.

  • HealthCor Management's largest Q1 2019 buy was Allergan plc: 617,760 shares worth $90.4M.
  • HealthCor Management added most to Zimmer Biomet in Q1 2019, an estimated $95.9M increase.
  • HealthCor Management's biggest Q1 2019 reduction was Intuitive Surgical, cutting an estimated $135M.
  • HealthCor Management fully exited Regeneron Pharmaceuticals in Q1 2019, selling an estimated $165M.
  • HealthCor Management's ten largest holdings make up 48% of its $2.48B portfolio in Q1 2019.
  • HealthCor Management opened 27 new positions and closed 18 in Q1 2019.
  • HealthCor Management's portfolio value fell 23% quarter-over-quarter to $2.48B.

Based on HealthCor Management's 13F filing for Q1 2019, filed 15 May 2019.